Align Technology Announces Third Quarter Fiscal 2008 Results
SANTA CLARA, Calif., Oct 28, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Align Technology, Inc. (Nasdaq: ALGN) today reported financial results for the third quarter of fiscal 2008, ended September 30, 2008.
Total net revenues for the third quarter of fiscal 2008 (Q3 08) were $75.2 million compared to $71.5 million reported in the third quarter of 2007 (Q3 07) and compared to $79.9 million reported in the second quarter of 2008 (Q2 08).
On a generally accepted accounting principles (GAAP) basis, net profit for Q3 08 was $5.2 million, or $0.08 per diluted share. This is compared to net profit of $9.5 million, or $0.13 per diluted share in Q3 07, and net profit of $4.0 million, or $0.06 per diluted share in Q2 08. Stock-based compensation expense included in Q3 08 net profit was $4.4 million, compared to $3.4 million in Q3 07, and $4.8 million in Q2 08.
"I am pleased with our results during these challenging times," said Thomas M. Prescott, president and CEO of Align Technology. "We are committed to continuing investment in new products and our key strategic initiatives while lowering our overall cost structure, which will position the Company for renewed growth and profitability as the environment improves."
Non-GAAP net profit for Q3 08 was $7.4 million, or $0.11 per diluted share. This is compared to non-GAAP net profit of $9.5 million, or $0.13 per diluted share in Q3 07, and non-GAAP net profit of $4.0 million, or $0.06 per diluted share in Q2 08.
Non-GAAP financial measures should be considered in addition to results prepared in accordance with GAAP, but should not be considered a substitute for, or superior to, GAAP results. A detailed reconciliation between GAAP and non-GAAP information is contained in the tables following the financial tables of this release.
Q3 08 Operating Results Key GAAP Operating Results Q3 08 Q2 08 Q3 07 Gross Margin 75.0% 74.7% 74.6% Operating Expense $50.7M $55.8M $44.9M Operating Margin 7.6% 4.8% 11.7% Net Profit $5.2M $4.0M $9.5M Earnings Per Diluted Share (EPS) $0.08 $0.06 $0.13 Key Non-GAAP Operating Results Q3 08 Q2 08 Q3 07 Non-GAAP Operating Expense $48.5M $55.8M $44.9M Non-GAAP Net Profit $7.4M $4.0M $9.5M Non-GAAP Earnings Per Diluted Share (EPS) $0.11 $0.06 $0.13
Liquidity and Capital Resources
As of September 30, 2008, Align had $114.3 million in cash, cash equivalents, and short term marketable securities compared to $127.9 million as of December 31, 2007. During Q3 08, Align purchased 930,373 shares at an average price of $12.62 per share for a total of $11.7 million. There remains $10.7 million under the Company's existing stock repurchase authorization.
Key Business Metrics
The following table highlights business metrics for Align's third quarter of 2008. Additional historical information is available on the Company's website at http://investor.aligntech.com.
Revenue by Channel: Q3 08 Q3 08/Q2 Q3 08/Q3 08 07 % Change % Change U.S. Orthodontists $22.3 (4.2%) (0.8%) U.S. GP Dentists $35.2 (3.9%) 1.0% International $15.1 (8.0%) 31.1% Training and Other $2.6 (28.3%) (1.3%) Total Revenue $75.2 (5.9%) 5.2% Average Selling Price (ASP): Q3 08 Q3 08/Q2 Q3 08/Q3 08 07 % Change % Change Total Worldwide Blended ASP $1,390 0.0% 5.3% Total Worldwide ASP excluding Invisalign Express $1,500 0.0% 4.9% U.S. Orthodontists Blended ASP $1,290 0.0% 4.9% U.S. GP Dentists Blended ASP $1,360 1.5% 3.8% International $1,660 (2.4%) 5.1% Number of Cases Shipped: Q3 08 Q3 08/Q2 Q3 08/Q3 08 07 % Change % Change U.S. Orthodontists - Full Invisalign 15,000 1.1% (1.1%) U.S. Orthodontists - Invisalign Express 2,970 (8.6%) (5.1%) U.S. GP Dentists - Full Invisalign 21,070 (4.8%) (3.7%) U.S. GP Dentists - Invisalign Express 4,620 (7.0%) 0.4% International- Full Invisalign 8,950 (6.0%) 25.0% International- Invisalign Express 190 18.8% 46.2% Total Cases Shipped 52,800 (3.8%) 1.4% Number of Doctors Cases were Shipped to: Q3 08 U.S. Orthodontists 3,730 U.S. GP Dentists 10,920 International 2,900 Total Doctors Cases were Shipped to Worldwide 17,550 Number of Doctors Trained Worldwide: Q3 08 Cumulative U.S. Orthodontists 90 8,600 U.S. GP Dentists 1,030 31,300 International 330 13,670 Total Doctors Trained Worldwide 1,450 53,570 Multiple Case Doctors (Cumulative as of): Q3 08 U.S. Orthodontists 90.6% U.S. GP Dentists 86.4% International 77.3% Doctors Starting Invisalign Treatment (Cumulative as of): Q3 08 U.S. Orthodontists 7,030 U.S. GP Dentists 24,900 International 7,740 Total Doctors Starting Invisalign Treatment 39,670 Doctor Utilization Rates*: Q3 08 Q2 08 Q3 07 U.S. Orthodontists 4.8 4.9 4.9 U.S. GP Dentists 2.4 2.5 2.6 International 3.2 3.3 3.1 Total Utilization Rate 3.0 3.1 3.2 * Utilization = # of cases/# of doctors to whom cases were shipped
For the fourth quarter of fiscal 2008 (Q4 08), Align Technology expects net revenues to be in a range of $72.5 million to $76.5 million. GAAP earnings per diluted share for Q4 08 is expected to be in a range of $0.01 to $0.03. Non-GAAP earnings per diluted share for Q4 08 is expected to be in a range of $0.06 to $0.09. Stock-based stock compensation expense for Q4 08 is expected to be approximately $4.1 million.
For fiscal 2008, Align Technology expects net revenues to be in a range of $302.5 million to $306.5 million. The Company continues to expect the increase in deferred revenue for fiscal 2008 to be in the range of $5 million to $8 million primarily associated with new products, which will be recognized in future periods, bringing the Company's total deferred revenue balance at the end of 2008 to a range of $17 million to $20 million. GAAP earnings per diluted share for fiscal 2008 is expected to be in a range of $0.22 to $0.24. Non-GAAP earnings per diluted share for fiscal 2008 is expected to be in a range of $0.31 to $0.33. Stock-based compensation expense for fiscal 2008 is expected to be approximately $17.3 million.
A more comprehensive business outlook is available following the financial tables of this release.
On October 23, 2008 Align, announced a restructuring plan to increase efficiencies across the organization and lower the Company's overall cost structure. The restructuring plan includes a total reduction of 110 full time headcount in Santa Clara, California. As part of these actions, Align will record a restructuring charge estimated to be approximately $5 million, of which approximately $3.5 million will be realized in Q4 08 and the remainder over the first half of 2009. This is in addition to the restructuring charge that the Company announced in July 2008. For more information, please see Align's press release titled, "Align Technology Announces Restructuring Plan."
Align Web Cast and Conference Call
Align Technology will host a conference call today, October 28, 2008 at 4:30 p.m. ET, 1:30 p.m. PT, to review its third quarter fiscal 2008 results, discuss future operating trends and business outlook. The conference call will also be web cast live via the Internet. To access the web cast, go to the "Events & Presentations" section under Company Information on Align Technology's Investor Relations web site at http://investor.aligntech.com. To access the conference call, please dial 201-689-8341 approximately fifteen minutes prior to the start of the call. If you are unable to listen to the call, an archived web cast will be available beginning approximately one hour after the call's conclusion and will remain available for approximately 12 months. Additionally, a telephonic replay of the call can be accessed by dialing 877-660-6853 with account number 292 followed by # and conference number 289246 followed by #. The replay must be accessed from international locations by dialing 201-612-7415 and using the same account and conference numbers referenced above. The telephonic replay will be available through 5:30 p.m. ET on November 11, 2008.
About Align Technology, Inc.
Align Technology designs, manufactures and markets Invisalign, a proprietary method for treating malocclusion, or the misalignment of teeth. Invisalign corrects malocclusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, Invisalign significantly reduces the aesthetic and other limitations associated with braces. Invisalign is appropriate for treating adults and teens. Align Technology was founded in March 1997 and received FDA clearance to market Invisalign in 1998. Today, the Invisalign product family includes Invisalign, Invisalign Teen, Invisalign Assist, Invisalign Express, and Vivera Retainers.
To learn more about Invisalign or to find a certified Invisalign doctor in your area, please visit http://www.invisalign.com or call 1-800-INVISIBLE.
About non-GAAP Financial Measures
To supplement our consolidated financial statements and our business outlook, we use the following non-GAAP financial measures: non-GAAP operating expenses, non-GAAP net profit, non-GAAP earnings per share, which exclude the effect of charges associated with the restructuring. The presentation of this financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. For more information on these non-GAAP financial measures, please see the tables captioned "Business Outlook Summary" included at the end of this release.
We use these non-GAAP financial measures for financial and operational decision making and as a means to evaluate period-to-period comparisons. Our management believes that these non-GAAP financial measures provide meaningful supplemental information regarding our "core operating performance". Management believes that "core operating performance" represents Align's performance in the ordinary, ongoing and customary course of its operations. Accordingly, management excludes from "core operating performance" certain expenses and expenditures that may not be indicative of our operating performance including discrete cash charges that are infrequent or one-time in nature. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting and analyzing future periods. These non-GAAP financial measures also facilitate management's internal evaluation of period-to-period comparisons. We believe these non-GAAP financial measures are useful to investors both because (1) they allow for greater transparency with respect to key metrics used by management in its financial and operational decision making and (2) they are provided to and used by our institutional investors and the analyst community to facilitate comparisons with prior and subsequent reporting periods.
This news release, including the tables below, contains forward-looking statements, including statements regarding, the expected amount of and timing of the charges to be incurred in connection with the restructuring and Align's anticipated financial results and certain business metrics for the fourth quarter and full year of 2008, including anticipated revenue and deferred revenue, gross profit, gross margin, operating expense, net profit, earnings per share, percentage of revenue by channel, case shipments and average selling prices. Forward-looking statements contained in this news release and the tables below relating to expectations about future events or results are based upon information available to Align as of the date hereof. Readers are cautioned that these forward-looking statements are only predictions and are subject to risks, uncertainties and assumptions that are difficult to predict. As a result, actual results may differ materially and adversely from those expressed in any forward-looking statement. Factors that might cause such a difference include, but are not limited to, failure to achieve the expected cost savings and efficiencies related to the restructuring, including a delay in the implementation of the relocation of certain customer facing organizations from Santa Clara, California to Costa Rica and greater than anticipated costs resulting from the relocation, changes in the size of the expected restructuring charge, loss of key personnel responsible for interpreting the relocation in a timely manner, failure to effectively manage the relocation resulting in decreased customer service levels, the possibility that the development and release of new products does not proceed in accordance with the anticipated timeline, the possibility that the market for the sale of these new products may not develop as expected, the risks relating to Align's ability to sustain or increase profitability or revenue growth in future periods while controlling expenses, continued customer demand for Invisalign and new products, changes in consumer spending habits as a result of, among other tings, prevailing economic conditions, levels of employment, salaries and wages and consumer confidence, the timing of case submissions from our doctors within a quarter, acceptance of Invisalign by consumers and dental professionals, Align's third party manufacturing processes and personnel, foreign operational, political and other risks relating to Align's international manufacturing operations, Align's ability to protect its intellectual property rights, competition from manufacturers of traditional braces and new competitors, Align's ability to develop and successfully introduce new products and product enhancements, and the loss of key personnel. These and other risks are detailed from time to time in Align's periodic reports filed with the Securities and Exchange Commission, including, but not limited to, its Annual Report on Form 10-K for the fiscal year ended December 31, 2007, which was filed with the Securities and Exchange Commission on February 26, 2008. Align undertakes no obligation to revise or update publicly any forward-looking statements for any reason.
Investor Relations Contact Press Contact Shirley Stacy Shannon Mangum Henderson Align Technology, Inc. Ethos Communication, Inc. (408) 470-1150 (678) 540-9222 email@example.com firstname.lastname@example.org UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share data) Three Months Ended Nine Months Ended Sept. 30, Sept. 30, Sept. 30, Sept. 30, 2008 2007 2008 2007 Net revenues $75,173 $71,451 $ 229,851 $211,815 Cost of revenues 18,766 18,132 58,617 55,908 Gross profit 56,407 53,319 171,234 155,907 Operating expenses: Sales and marketing 28,214 24,226 88,737 71,729 General and administrative 14,395 13,949 45,905 38,014 Research and development 5,918 6,749 20,214 19,117 Restructuring 2,189 - 2,189 - Patients First Program - - - (1,796) Total operating expenses 50,716 44,924 157,045 127,064 Profit from operations 5,691 8,395 14,189 28,843 Interest and other income, net 264 1,108 1,673 2,243 Profit before income taxes 5,955 9,503 15,862 31,086 Provision for income taxes (798) (43) (1,371) (1,030) Net profit $5,157 $9,460 $14,491 $30,056 Net profit per share - basic $0.08 $0.14 $0.21 $0.45 - diluted $0.08 $0.13 $0.21 $0.42 Shares used in computing net profit per share - basic 67,367 67,970 68,330 66,709 - diluted 68,704 72,230 69,906 71,058 UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands) September 30, December 31, 2008 2007 ASSETS Current assets: Cash and cash equivalents $79,756 $89,140 Marketable securities, short-term 34,499 38,771 Accounts receivable, net 48,872 44,850 Inventories, net 3,015 2,910 Other current assets 7,412 8,846 Total current assets 173,554 184,517 Property and equipment, net 29,568 25,320 Goodwill and intangible assets, net 8,966 11,093 Other long-term assets 4,432 1,831 Total assets $216,520 $222,761 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $7,485 $9,222 Accrued liabilities 33,877 39,875 Deferred revenues 15,380 12,362 Total current liabilities 56,742 61,459 Other long term liabilities 124 148 Total liabilities 56,866 61,607 Total stockholders' equity 159,654 161,154 Total liabilities and stockholders' equity $216,520 $222,761 RECONCILIATION OF GAAP TO NON-GAAP KEY FINANCIAL METRICS Reconciliation of GAAP to Non-GAAP Operating Expenses (in thousands) Three Months Ended September June September 30, 30, 30, 2008 2008 2007 GAAP Operating expenses $50,716 $55,787 $44,924 Restructuring Cost (2,189) - - Non-GAAP Operating expenses $48,527 $55,787 $44,924 Reconciliation of GAAP to Non-GAAP Net Profit (Loss) (in thousands, except per share amounts) Three Months Ended September June September 30, 30, 30, 2008 2008 2007 GAAP Net profit $5,157 $4,030 $9,460 Restructuring 2,189 - - Tax effect on Restructuring 85 - - Non-GAAP Net profit $7,431 $4,030 $9,460 Diluted Net profit per share: GAAP $0.08 $0.06 $0.13 Non-GAAP $0.11 $0.06 $0.13 Shares used in computing diluted net profit per share 68,704 69,916 72,230 BUSINESS OUTLOOK SUMMARY (unaudited)
The outlook figures provided below and elsewhere in this press release are approximate in nature since Align's business outlook is difficult to predict. Align's future performance involves numerous risks and uncertainties and the company's results could differ materially from the outlook provided. Some of the factors that could affect Align's future financial performance and business outlook are set forth under ''Forward Looking Information'' above in this press release. This outlook excludes the effects of any stock repurchases.
Financials (including reconciliation of GAAP to non-GAAP financial measures): (in millions, except per share amounts and percentages) Q4 2008 GAAP Adjustment(a) Non-GAAP Net Revenue $72.5 - $76.5 $72.5 - $76.5 Gross Margin 72.5% - 73.0% 72.5% - 73.0% Operating Expenses $52.1 - $53.6 $4.0 (a)$48.1 - $49.6 Net Profit % 1% - 3% 5% 6% - 8% Net Profit per Diluted Share $0.01 - $0.03 $0.05 - $0.06 $0.06 - $0.09 - $0.33 Stock Based Compensation Expense: Cost of Revenues $0.4 $0.4 Operating Expenses $3.7 $3.7 Total Stock Based Compensation Expense $4.1 $4.1 (a) Restructuring charges Business Metrics: Q4 2008 Case Shipments 52.5K - 55.0K Cash $115M - $120M DSO ~59 days Capex $3.0M - $5.0M Depreciation & Amortization $2.0M - $3.0M Diluted Shares Outstanding 68.1 FY 2008 FY 2008 Adjustment(a) Non-GAAP Net Revenue $302.5 - $306.5 $302.5 - $306.5 Gross Margin 74.0% - 74.1% 74.0% - 74.1% Operating Expenses $209.1 - $210.6 $6.2 (a)$202.9 - $204.4 Net Profit % 5% - 6% 2% 7% - 8% Net Profit per Diluted Share $0.22 - $0.24 $0.09 $0.31 - $0.33 Stock Based Compensation Expense: Cost of Revenues $1.7 $1.7 Operating Expenses $15.6 $15.6 Total Stock Based Compensation Expense $17.3 $17.3 Increase in Deferred Revenue $5.0 - $8.0 $5.0 - $8.0 Total Deferred Revenue Balance $17.0 - $20.0 $17.0 - $20.0 (a) Restructuring charges Business Metrics: FY 2008 Case Shipments 211.9K - 214.4K Cash $115M - $120M DSO ~59 days Capex $15.0M - $17.0M Depreciation & Amortization $13.0M - $14.0M Diluted Shares Outstanding 69.4
SOURCE Align Technology, Inc.
Copyright (C) 2008 PR Newswire. All rights reserved
News Provided by COMTEX